Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules

Feb 08, 2021 3:24pm EST

Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million

Jan 21, 2021 9:28am EST

Baudax Bio to Present at the H.C. Wainwright BioConnect 2021 Conference

Jan 06, 2021 7:00am EST

Baudax Bio Announces $12 Million Offering Priced at a Premium to Market

Dec 17, 2020 7:00am EST

Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference

Nov 30, 2020 4:05pm EST

Baudax Bio Announces $12 Million Offering Priced at a Premium to Market

Nov 23, 2020 8:00am EST

Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology

Nov 20, 2020 7:00am EST

Baudax Bio Announces an additional Orange Book listed patent for ANJESO®

Nov 19, 2020 7:00am EST

Baudax Bio Reports Third Quarter 2020 Financial Results

Nov 09, 2020 7:05am EST

Baudax Bio to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

Nov 02, 2020 7:05am EST